PART B: VALORISATION PLAN
SECTION I: ESTIMATION OF COSTS
1 |
Taking into account the rest of the cost evaluation please provide an overall estimation of the total costs for full deployment/production of the R & D result. |
… in terms of IPR protection | |
The product has already started a patent process and costs are estimated to be about € 15.500 in 3 years.
|
|
…in terms of product development | |
The costs for the software development are estimated about € 5.000 in 3 years.
In terms of personnel, at least one person in the first year will be engaged (up to the 3 in the third year): costs are going from € 7.000 to € 14.000.
|
|
…in terms of mass production | |
In term of mass production costs will vary from € 20.000 in the first year to € 50.000 in the third year.
|
|
… in terms of marketing | |
Investments in marketing are foreseen but are not going to be very incisive on the overall costs. In fact, considering the product, a lot can be done on line via web. |
2 |
Based on the above assessment as well as the marketing information please provide the correct estimation of the price for R&D product in correlation with costs |
|||||
|
Year 1 |
Year 2 |
Year 3 |
Year 4 |
Year 5 |
|
Fixed costs |
10.000 |
13.000 |
18.000 |
|
|
|
Personnel |
7.000 |
14.000 |
14.000 |
|
|
|
Other running costs |
5.000 |
15.000 |
22.000 |
|
|
|
Marketing costs |
|
|
|
|
|
|
TOTAL EXPECTED COSTS |
22.000 |
42.000 |
54.000 |
|
|
|
Price per Unit |
|
|
|
|
|
|
Type of Unit |
|
|||||
Number of Units |
|
|
|
|
|
|
TOTAL Expected Revenues |
25.500 |
50.000 |
70.000 |
|
|
|
CASH FLOW REQUIRED (REVENUES-COSTS) |
3.500 |
8.000 |
16.000 |
|
|
|
TOTAL CAPITAL required for 3 years |
118.000 |
|||||
SECTION 2: QUALITATIVE FACTORS
3 |
Dimension of identified target groups |
The product is targeting a global market as it is addressing the sector of electronic devices being represented by PCs, notebooks, mobile phones.
The main target group is represented by companies producing electronic devices but also companies selling electronic devices. In both cases an international level is targeted.
|
4 |
Evaluation of financial Risks for R&D result |
The project is well structured and the complete business plan has already been developed. There is a good starting knowledge of the referent market and an interest about the product has already been expressed by an US company. There are no special financial risks to be underlined for R&D result.
|
SECTION 3: IDENTIFICATION OF FINANCING SOURCES
After evaluating all the above mentioned criteria, please tick the best financing source for the achievement of R&D result (i.e. own capitals, banking credits, venture capital, business angels, etc)
1. European Funding Define relevance of the product with the following potential funding sources and comment |
FP7 Programme – ICT work programme to be explored with attention to Cooperation calls http://cordis.europa.eu/fp7/ict/home_en.html CIP-ICT-PSP – Work programme 2011 http://ec.europa.eu/information_society/activities/ict_psp/index_en.htm For further develop the Research, in cooperation with EU partners, the two above mentioned EU programmes can be addressed. Ai international level, research funding opportunities can be listened at the following link
|
2. National Funding |
n.a. |
3. Private funding |
n.a.
|
4. Other |
FVG Regional funding for Applied Research in cooperation with local companies (LR 26, LR4, POR-FESR). In these cases, the applicant is generally the company (that have the specific interest to develop a Research and is willing to invest on that – the regional funds is only covering a part of the costs, there is always a partner co financing).
|
SECTION 3: FINAL EVALUATION
It is requested a final evaluation considering the funding opportunities you believe most suitable for the exploitation of the R&D result, considering the possibility of the creation of a spin-off, further research, in particular, a cost/benefit analysis and a financial projection for the R&D result, type of collaboration identified (i.e. Licensing Agreement, Technical Cooperation, Joint Venture, Manufacturing Agreement, Commercial Agreement with Technical Assistance, Creation of a spin-off, Joint further development)… |
The R&D has a high potential of exploitation.
|
Decision of evaluation (Please keep only the appropriate)
- The R&D has a high potential of exploitation
- The R&D result needs minor revisions
- The R&D result needs moderate revisions
- The R&D result needs major revisions
- The R&D result has no potential of exploitation